Policy Talk

Trainees are often unaware of how the U.S. legislative and executive branches impact their current (or long-term) research interests. Below is a chart that illustrates the interrelationships among four major actors within the biomedical industry: Federal government (executive branch), U.S. Congress (legislative branch), industry, scientific societies (and other science-based nonprofits), and U.S. postsecondary institutions, particularly […]

read

DAC Member Angela Sharpe talks politics…and science

Diversity Advisory Committee (DAC) member Angela Sharpe serves as Deputy Director of the Consortium of Social Science Associations (COSSA) and leads the Collaborative for Enhancing Diversity in Science (CEDS) in Washington, D.C. In this podcast for the DLSP, Sharpe discusses the role of the executive branch in science and talent development.         […]

read

KUDOS

Dr. Cherie Butts (KSF Class of 2009) was appointed to the September 2016 Board of Overseers at Harvard’s Beth-Israel Deaconess Medical Center, serving on the Research Oversight Committee. Good work! Dr. Marcus Jones (KSF Class of 2011) has left Human Longevity in San Diego to accept a position at Regeneron in New York as  Sr. […]

read

WORTH MENTIONING

The DLSP is pleased to welcome two new DAC members: Drs. Anastacia Berzat and Harlan Jones Anastacia Berzat, Ph.D., is Associate Director of Diversity & Inclusion for Novartis Institutes for BioMedical Research in Cambridge, MA.  Please read her article, “Five things to look for in a scientific mentor.”  I think she’s spot on.  I especially […]

read
Page 3 of 41234